Evaluate BIIB stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in BIIB? | Glauxie AI

Q: What are the risks of investing in BIIB?

Biogen Inc. (BIIB) operates in the Drug Manufacturers - General industry (Healthcare sector). The company is led by CEO Christopher A. Viehbacher. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and... Employees: 7,500.

Q: How much debt does BIIB have?

Review BIIB total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is BIIB a good long-term investment?

Evaluate BIIB as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in BIIB?

🦉

Biogen Inc. (BIIB)

Company Overview

Sector / IndustryHealthcare / Drug Manufacturers - General

CEOChristopher A. Viehbacher

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat...

Key Executives

Name	Title
Adam Keeney	Executive Vice President & Head of Corporate Development
Alisha A. Alaimo	President & Head of North America
Anabella Villalobos	Head of Biotherapeutics & Medicinal Sciences
Christopher A. Viehbacher	President, Chief Executive Officer & Director
Fraser Hall	President & Head of Intercontinental Region
Ginger Gregory	Executive Vice President & Chief Human Resources Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

BIIB Profile Financials

Is BIIB stock safe? How much debt does BIIB have? Is BIIB a good long-term investment?